Humanwell Healthcare Group Co Ltd
SSE:600079
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Humanwell Healthcare Group Co Ltd
SSE:600079
|
CN |
|
A
|
Artrya Ltd
ASX:AYA
|
AU |
|
L
|
Lam Thao Fertilizers and Chemicals JSC
VN:LAS
|
VN |
|
EnTie Commercial Bank Ltd
TWSE:2849
|
TW |
|
I
|
Instadose Pharma Corp
OTC:INSD
|
US |
|
Christian Dior SE
OTC:CHDRF
|
FR |
Wall Street
Price Targets
Price Targets Summary
Humanwell Healthcare Group Co Ltd
According to Wall Street analysts, the average 1-year price target for
Humanwell Healthcare Group Co Ltd
is 23.64 CNY
with a low forecast of 22.43 CNY and a high forecast of 25.35 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Humanwell Healthcare Group Co Ltd's stock price target?
Price Target
23.64
CNY
According to Wall Street analysts, the average 1-year price target for
Humanwell Healthcare Group Co Ltd
is 23.64 CNY
with a low forecast of 22.43 CNY and a high forecast of 25.35 CNY.
What is Humanwell Healthcare Group Co Ltd's Revenue forecast?
Projected CAGR
14%
For the last 14 years the
compound annual growth rate for
Humanwell Healthcare Group Co Ltd's revenue is
14%.
The projected
CAGR
for the next 2 years is
14%.
What is Humanwell Healthcare Group Co Ltd's Operating Income forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
Humanwell Healthcare Group Co Ltd's operating income is
15%.
The projected
CAGR
for the next 2 years is
13%.
What is Humanwell Healthcare Group Co Ltd's Net Income forecast?
Projected CAGR
21%
For the last 14 years the
compound annual growth rate for
Humanwell Healthcare Group Co Ltd's net income is
14%.
The projected
CAGR
for the next 2 years is
21%.